Cas:64297-92-3 2-bromo-N-(2-phenylethyl)acetamide manufacturer & supplier

We serve Chemical Name:2-bromo-N-(2-phenylethyl)acetamide CAS:64297-92-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2-bromo-N-(2-phenylethyl)acetamide

Chemical Name:2-bromo-N-(2-phenylethyl)acetamide
CAS.NO:64297-92-3
Synonyms:N-phenethyl-2-bromoacetamide;2-bromo-N-phenethyl-acetamide
Molecular Formula:C10H12BrNO
Molecular Weight:242.11200
HS Code:2924299090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:391.241ºC at 760 mmHg
Density:1.388g/cm3
Index of Refraction:1.56
PSA:29.10000
Exact Mass:241.01000
LogP:2.13110

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like N-phenethyl-2-bromoacetamide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-bromo-N-phenethyl-acetamide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-bromo-N-phenethyl-acetamide Use and application,2-bromo-N-phenethyl-acetamide technical grade,usp/ep/jp grade.


Related News: The iLet Bionic Pancreas System is a pocket-sized, wearable investigational medical device that is designed to autonomously control blood-sugar levels. 2-bromo-N-(2-phenylethyl)acetamide manufacturer Different cell types can be affected, although the most common finding in MDS is a shortage of red blood cells (anaemia). Patients with higher-risk MDS may progress to the development of acute leukaemia. 2-bromo-N-(2-phenylethyl)acetamide supplier Only when the drug substance is processed into a pharmaceutical preparation can it become a drug for clinical application. 2-bromo-N-(2-phenylethyl)acetamide vendor The rigosertib Pre-approval Access Program is expected to launch in first half of 2020 and will allow Inceptua to supply intravenous rigosertib within designated countries, primarily and initially concentrated in selected countries in Europe, in response to physician requests for patients with higher-risk MDS who have exhausted all available treatment options, and are not eligible for or have no access to the INSPIRE study. 2-bromo-N-(2-phenylethyl)acetamide factory The iLet Bionic Pancreas System is a pocket-sized, wearable investigational medical device that is designed to autonomously control blood-sugar levels.